Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Augmedix (AUGX)
NASDAQ:AUGX
Augmedix (AUGX) Stock Price & Analysis
68 Followers
AUGX Stock Chart & Stats
Day’s Range$2.75 - $2.87
52-Week Range― - ―
Previous Close$2.79
Volume320.58K
Average Volume (3M)N/A
Market Cap
$138.42M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 09, 2024EPS Estimate
-$0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$6.10Price Target Upside114.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Augmedix News
Bulls Say, Bears Say
Bulls Say
Earnings GrowthImpressive fourth quarter performance with all metrics exceeding expectations has led to an increased price target, reaffirming the company's growth trajectory.
Financial PerformanceRobust annual recurring revenue growth showcases the company's solid financial health and its ability to sustainably increase its market share.
Product LaunchThe launch of Augmedix Go has generated a strong buy sentiment, reflecting the company's continuing innovation and market expansion.
Bears Say
Earnings GuidanceReduce Estimates & PT to $1.25 on Lower Revenue Guidance & Shareholder Update
Financial PerformanceWidening of 2024 adjusted EBITDA losses despite slightly higher revenue projections for 2023 and 2024.
ValuationAUGX trades at a high EV/revenue multiple of 2.4x based on projected 2025 revenues, surpassing the peer group average by a significant margin.
---
Ownership Overview
54.98% Insiders
5.69% Mutual Funds
3.34% Other Institutional Investors
35.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AUGX FAQ
What was Augmedix’s price range in the past 12 months?
Currently, no data Available
What is Augmedix’s market cap?
Currently, no data Available
When is Augmedix’s upcoming earnings report date?
Augmedix’s upcoming earnings report date is May 09, 2024 which is in 12 days.
How were Augmedix’s earnings last quarter?
Augmedix released its earnings results on Mar 18, 2024. The company reported -$0.09 earnings per share for the quarter, beating the consensus estimate of -$0.098 by $0.008.
Is Augmedix overvalued?
According to Wall Street analysts Augmedix’s price is currently Undervalued.
Does Augmedix pay dividends?
Augmedix does not currently pay dividends.
What is Augmedix’s EPS estimate?
Augmedix’s EPS estimate is -$0.13.
How many shares outstanding does Augmedix have?
Currently, no data Available
What happened to Augmedix’s price movement after its last earnings report?
Augmedix reported an EPS of -$0.09 in its last earnings report, beating expectations of -$0.098. Following the earnings report the stock price went up 18.919%.
Which hedge fund is a major shareholder of Augmedix?
Among the largest hedge funds holding Augmedix’s share is Ardsley Advisory Partners. It holds Augmedix’s shares valued at 3M.
---
Augmedix Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.10 (114.04% Upside)
$6.10 (114.04% Upside)
Blogger Sentiment
Bullish
AUGX Sentiment 85%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 12.2%
Last 30 Days ▼ 12.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.42%
12-Months-Change
Fundamentals
Return on Equity
-154.68%
Trailing 12-Months
Asset Growth
98.31%
Trailing 12-Months
Company Description
Augmedix
Augmedix Inc humanizes the clinician-patient experience by enabling clinicians to focus on what matters most, delivering high-quality patient care. It converts natural clinician-patient conversation into medical documentation and provides real-time administrative support, including referrals, orders, and reminders. The service, which supports over 35 specialties, delivers timely, accurate and comprehensive medical documentation to several of the healthcare systems in the U.S. and to hundreds of independent clinicians nationwide. Augmedix focuses on saving clinicians 2-3 hours per day, improve clinician productivity by as much as 20%, and increase clinicians' satisfaction with work-life balance over 40%.
---
AUGX Earnings Call
Q4 2024
0:00 / 0:00
---
AUGX Stock 12 Months Forecast
Average Price Target
$6.10
▲(114.04% Upside)
Technical Analysis
Best Analysts Covering AUGX
1 Year
1 Year Success Rate
6/15 ratings generated profit
1 Year Average Return
+60.51%
reiterated a buy rating last month
Copying Allen Klee's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +60.51% per trade.
---